InsiderTrades.com logo

Susan Burwig Biography and Net Worth

VP of Medpace
  • LinkedIn
  • Phone
  • Email
  • Website


Susan E. Burwig serves as Executive Vice President - Operations of the Company. She joined Medpace in August 1993 and has served in various key leadership roles within the Clinical Operations department. From February 2003 to May 2015, Ms. Burwig served as Senior Vice President, Clinical Operations, overseeing clinical trial management, clinical monitoring, start-up, including feasibility, and new business proposals. In June 2015, Ms. Burwig was appointed Senior Vice President, Operations, and in January 2017 she was named as Executive Vice President, Operations. Prior to joining Medpace, Ms. Burwig held several clinical roles, including leading heart failure clinical research studies at the University of Cincinnati. Ms. Burwig received her Bachelor of Science in Nursing as well as an MA in Sports Administration from Kent State University.

What is Susan E. Burwig's net worth?

The estimated net worth of Susan E. Burwig is at least $4.88 million as of March 15th, 2024. Ms. Burwig owns 15,181 shares of Medpace stock worth more than $4,877,200 as of March 26th. This net worth approximation does not reflect any other investments that Ms. Burwig may own. Additionally, Ms. Burwig receives a salary of $1,120,000.00 as VP at Medpace. Learn More about Susan E. Burwig's net worth.

How old is Susan E. Burwig?

Ms. Burwig is currently 61 years old. There are 5 older executives and no younger executives at Medpace. The oldest executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who is 68 years old. Learn More on Susan E. Burwig's age.

What is Susan E. Burwig's salary?

As the VP of Medpace Holdings, Inc., Ms. Burwig earns $1,120,000.00 per year. The highest earning executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who commands a salary of $1,650,000.00 per year. Learn More on Susan E. Burwig's salary.

How do I contact Susan E. Burwig?

The corporate mailing address for Ms. Burwig and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at investor@medpace.com. Learn More on Susan E. Burwig's contact information.

Has Susan E. Burwig been buying or selling shares of Medpace?

Susan E. Burwig has not been actively trading shares of Medpace over the course of the past ninety days. Most recently, Susan E. Burwig sold 102 shares of the business's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $403.00, for a transaction totalling $41,106.00. Following the completion of the sale, the vice president now directly owns 15,181 shares of the company's stock, valued at $6,117,943. Learn More on Susan E. Burwig's trading history.

Who are Medpace's active insiders?

Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.

Are insiders buying or selling shares of Medpace?

In the last twelve months, Medpace insiders bought shares 1 times. They purchased a total of 2 shares worth more than $652.22. In the last twelve months, insiders at the sold shares 5 times. They sold a total of 29,621 shares worth more than $11,816,851.63. The most recent insider tranaction occured on February, 27th when General Counsel Stephen P Ewald bought 2 shares worth more than $652.22. Insiders at Medpace own 20.3% of the company. Learn More about insider trades at Medpace.

Information on this page was last updated on 2/27/2025.

Susan E. Burwig Insider Trading History at Medpace

See Full Table

Susan E. Burwig Buying and Selling Activity at Medpace

This chart shows Susan E Burwig's buying and selling at Medpace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal Insider BuyingTotal Insider Selling

Medpace Company Overview

Medpace logo
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Read More

Today's Range

Now: $320.55
Low: $319.45
High: $325.77

50 Day Range

MA: $337.16
Low: $317.93
High: $360.97

2 Week Range

Now: $320.55
Low: $302.01
High: $459.77

Volume

90,040 shs

Average Volume

288,728 shs

Market Capitalization

$9.77 billion

P/E Ratio

25.38

Dividend Yield

N/A

Beta

1.47